DYT1 (IMAGE)
Caption
As researchers hunt for new treatments for a rare movement disorder called dystonia, they are able to conduct drug screening tests by pushing the molecular culprit, the DYT1 protein (shown in green), to the wrong spot within cells.
Credit
Zac Caffall, Duke University
Usage Restrictions
None
License
Licensed content